Yasmeen Khan

The director James Cameron recently said a takeover would be disastrous for theatrical releases.

Netflix has said it would maintain a theatrical window and accused Cameron of joining Paramount's disinformation campaign.

As the two companies fight it out, Trump has weighed in with his own demands.

Over the weekend, he insisted that Netflix remove longtime Democratic official Susan Rice from its board.

The BBC's Amol Rajan asked Sarandos for his reaction in an interview yesterday.

Trump is a close ally to Larry Ellison, the father of Paramount's owner, David Ellison.

But he's also spoken fondly about Ted Sarandos, making the president's desire to influence events hard to predict.

Warner Brothers shareholders are set to vote on the Netflix deal next month.

As weight loss drugs explode in popularity, scientists are learning more about the possible benefits, risks, and their long-term effectiveness.

These GLP-1s, as they're called, work by suppressing diet through insulin stimulation and slowing the passage of food through the stomach.

But The New Yorker has been looking into how they could benefit one of America's biggest public health challenges, addiction.

Dhruv Kular is a physician and a contributing writer at The New Yorker.

The studies are in early days, but Kular notes that so far, they offer some promising results.

Some researchers believe medications like Ozempic can manipulate the brain's mesolimbic pathway, sometimes called the reward system.

This is where the brain releases dopamine if it's exposed to certain exciting or addictive activities.

In addition to looking at the research, Kular met some people being studied, like Mary.

That inspired Mary to sign up for a clinical trial studying the drug's effect on alcohol addiction.

She lost 55 pounds, but more importantly for her, she lost her taste for beer.

Hular cautions against seeing GLP-1s as a kind of miracle drug, and a minority of people in the study experienced side effects.

He talked to some people who said they found it difficult to experience pleasure at all.